Key points are not available for this paper at this time.
(1) To assess whether data collected during Enroll-HD visits are sufficient to study effects of tetrabenazine and olanzapine in Huntington disease (HD) and (2) to evaluate influence of these medicines on UHDRS motor scores and PBAs depression score.
Seliverstov et al. (Tue,) studied this question.